The overall goal of this research is to continue to characterize the toxic effects of methamphetamine (MA) and related drugs on a biochemical, morphological, and behavioral basis. MA, amphetamine (AMPH), methylenedioxyamphetamine (MDMA) and a number of related drugs are widely abused and are neurotoxic when used in high and/or repeatedly administered doses. Cocaine is another drug of abuse which has long-lasting effects after repeated administration. The extent, duration, and consequences of this toxicity are important to understanding and treating the consequences of these drugs of abuse. The purpose of this research is to extend what is known about the relatively short-term toxicity of these drugs to an investigation of the long-term toxicity and consequences of this toxicity. To achieve the goals of this research, we will determine the magnitude of the long-lasting toxic effects of MA, AMPH, and MDMA upon dopamine (DA) and 5-hydroxytryptamine (5HT) systems as a function of dose and drug-free time period. We will measure the amine levels, the number of high affinity uptake sites, changes in local glucose utilization and alterations in morphology as lone as 64 weeks after the drug has been discontinued. We will also test MA analogues such as N-ethylamphetamine and dimethylamphetamine to determine whether these analogues have toxic potential. Further, we have recently found that a long-term effect of repeated exposure to COC is an alteration of dopamine receptors in the brain. We do not know the extent, duration or consequences of this alteration. We will examine these parameters by determining the effects on receptor subtypes of repeated administration of cocaine, MA and toxic analogues. The long-term consequence of receptor modifications may be correlated with neurotoxicity and/or with behavioral changes that may result from repeated administration of these compounds. We will also investigate the behavioral consequences of drug-induced neurotoxicity. If behavior is altered by neurotoxic drugs or by drug challenge, it will suggest that there are direct behavioral consequences, or that function of particular neuronal systems are compromised by this drug-induced damage. These experiments will be crucial in predicting and treating the consequences of the ingestion of neurotoxic drugs commonly abused by humans.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA000085-21
Application #
3206718
Study Section
Special Emphasis Panel (SRCD (19))
Project Start
1971-05-01
Project End
1995-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
21
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Richards, J B; Baggott, M J; Sabol, K E et al. (1993) A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Res 627:254-60
Sabol, K E; Richards, J B; Seiden, L S (1992) The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine. Brain Res 582:129-33
Farfel, G M; Kleven, M S; Woolverton, W L et al. (1992) Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res 578:235-43
Farfel, G M; Vosmer, G L; Seiden, L S (1992) The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Brain Res 595:121-7
Sabol, K E; Richards, J B; Seiden, L S (1992) Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Res 585:421-4
Sabol, K E; Richards, J B; Seiden, L S (1992) Fenfluramine-induced increases in extracellular hippocampal serotonin are progressively attenuated in vivo during a four-day fenfluramine regimen in rats. Brain Res 571:64-72
Kleven, M S; Seiden, L S (1991) Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in rat striatum. Brain Res 557:340-3
Zacny, J P; Virus, R M; Woolverton, W L (1990) Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine. Pharmacol Biochem Behav 35:637-42
Kleven, M S; Perry, B D; Woolverton, W L et al. (1990) Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res 532:265-70
Kleven, M S; Woolverton, W L; Seiden, L S (1989) Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Res 488:121-5

Showing the most recent 10 out of 26 publications